Hikal Limited (HIKAL) — regulation 31

· NSE Neutral
📢 Key Event
Promoter group shareholding disclosed under SEBI Takeover Regulations.
🔄 What Changed
Promoter group shareholding disclosed under SEBI Takeover Regulations.
💡 Investor Takeaway
This confirms promoter holdings remain unencumbered and unchanged during the financial year.

Hikal Limited disclosed on April 6, 2026, that Kalyani Investment Company Limited and BF Investment Limited hold 38,667,375 shares (31.36%) and 3,273,375 shares (2.65%) respectively, as part of the promoter group in Hikal Limited as of March 31, 2026, under SEBI Takeover Regulations.

📄 View Original Announcement (PDF)

About Hikal Limited (HIKAL)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹2,484.02 Cr P/E: 33.4

View full HIKAL stock details →

📡 Get AI alerts when HIKAL files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track HIKAL — Free

📊 More HIKAL filings

See all HIKAL filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when HIKAL files new disclosures

Track HIKAL filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track HIKAL — Free

Free account · 2 AI queries/day